In PC cells, DHT-mediated AR signaling induced HIF-1α expression, and the dual treatment of enzalutamide and HIF-1α inhibition abrogated cell growth, induced apoptosis, and reduced VEGF levels more effectively than the administration of each treatment alone [25]. This evidence concerns the gene HIF1A and pachyonychia congenita.